Delivery Order SPE2DB20D3103-SPE2DB24FP2S6

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of cefpodoxime 200 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,437.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a completion date of March 7, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Cefpodoxime 100 mg tablets to the Defense Logistics Agency (DLA). The $1,198.85 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as...
This federal contract award, with ID SPE2DB20D7061|SPE2DB25FSMQ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.55, is a Delivery Order for the supply of Cefpodoxime 200 mg Tablets in 20-count packages. The contract is not designated as a set-aside and is a Firm Fixed Price agreement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,472.40 and an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of September 10, 2024 and a ceiling value of $2,690.24. The contract does not have a set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded numerous federal contracts to supply a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $2,141.48 and has an ultimate completion date of April 22, 2024. Amerisourcebergen provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to the U.S. Department of Defense (DoD) and other federal agencies. This delivery order is part of a larger...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of pharmaceutical products, including a tablet medication. The contract has a ceiling value of $13,929.10 and a completion date of January 13, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract is for the supply of pharmaceutical products and medical supplies, with a firm fixed price ceiling value of $2,577.88 and a completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. The company holds significant Indefinite Delivery Contracts (IDCs)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract has a ceiling value of $1,345.11 and will run through July 2024. It is a Firm Fixed Price contract with no set-aside designation. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP2S6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefpodoxime 200 mg tablets. The contract has a firm fixed price of $2,116.42 and an ultimate completion date of June 25, 2024. The contract is not set aside for any specific business category.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 9:58 AM